Tumor progression associated with erythropoiesis-stimulating agents.

Item

http://www.wikidata.org/entity/Q37328830

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Tumor progression associated with erythropoiesis-stimulating agents.

@en

Tumor progression associated with erythropoiesis-stimulating agents.

@nl

type

Item

label

Tumor progression associated with erythropoiesis-stimulating agents.

@en

Tumor progression associated with erythropoiesis-stimulating agents.

@nl

prefLabel

Tumor progression associated with erythropoiesis-stimulating agents.

@en

Tumor progression associated with erythropoiesis-stimulating agents.

@nl

P1476

Tumor progression associated with erythropoiesis-stimulating agents.

@en

P2093

Ashley M Newland

http://www.w3.org/2001/XMLSchema#string

Curtis D Black

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

Anemia, tumor hypoxemia, and the cancer patient.

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia.

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

P304

1865-1870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1L231

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23482053

http://www.w3.org/2001/XMLSchema#string

P698

19017828

http://www.w3.org/2001/XMLSchema#string